Issue 6, 2013

N-Acetyl-l-cysteine capped quantum dots offer neuronal cell protection by inhibiting beta (1–40) amyloid fibrillation

Abstract

This is the first work that revealed the neuro-protective effect of functionalized quantum dots against the cytotoxicity induced by beta-amyloid peptides. This study gives insight into the future treatment of Alzheimer's disease. It opens many avenues for the development of the next generation nanotechnology for biomedical and therapeutic applications.

Graphical abstract: N-Acetyl-l-cysteine capped quantum dots offer neuronal cell protection by inhibiting beta (1–40) amyloid fibrillation

Supplementary files

Article information

Article type
Communication
Submitted
31 Jan 2013
Accepted
28 Mar 2013
First published
17 Apr 2013

Biomater. Sci., 2013,1, 577-580

N-Acetyl-L-cysteine capped quantum dots offer neuronal cell protection by inhibiting beta (1–40) amyloid fibrillation

O. T. W. Ng, Y. Wong, H. Chan, J. Cheng, X. Qi, W. Chan, K. K. L. Yung and H. Li, Biomater. Sci., 2013, 1, 577 DOI: 10.1039/C3BM60029G

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements